Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
MYLOTARG Trockensub 5 mg Durchstf
Drug
Mylotarg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
akute myeloische Leukämie
07.16.1. – cytostatics
HAM – Human medicine
PULPI – powder for concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
12/5/2019
12/31/9999
Dosage strength
Mylotarg 5 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
akute myeloische Leukämie
01
Z – approved
Package
7680668790012
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
5 mg gemtuzumabum ozogamicinum
saccharum
dextranum 40
natrii chloridum
natrii dihydrogenophosphas monohydricus
dinatrii phosphas
12.54 mg natrium
dextranum 40
natrii chloridum
natrii dihydrogenophosphas monohydricus
dinatrii phosphas
12.54 mg natrium
Authorisation holder
7601001010604
Pfizer AG
Schärenmoosstrasse 99
8052 Zürich (ZH)
Schärenmoosstrasse 99
8052 Zürich (ZH)
Date of revision of the text
5/1/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.